The Clinical Neuropsychologist | 2019

Examination of the reliability and validity of the NAB Naming Test in a diverse clinical sample

 
 

Abstract


Abstract Objective: The Boston Naming Test, Second Edition (BNT-2) and the Neuropsychological Assessment Battery (NAB) Naming Test are common measures to assess visual confrontation naming ability. The comparably newer NAB Naming Test is a potential alternative to the BNT-2, given the latter’s history of criticism. A recent psychometric investigation of the NAB Naming Test demonstrated sufficient reliability and validity in a large clinical sample; however, their study was limited by a lack of ethnic, racial, and language diversity, all of which can impact scores on naming tests. Method: The present study examined convergent and discriminant validity and internal consistency of the NAB Naming Test in a diverse clinical sample comprised of 225 veterans (87.6% men, 51.1% White/Caucasian, 29.3% bilingual, 64.0% with cognitive impairment). All but three participants identified as White/Caucasian, Hispanic/Latino or Black/African American. These psychometric properties were examined for the overall sample and for monolingual (English) and bilingual (English/Spanish) participants separately. Results: As expected, the NAB Naming Test demonstrated sufficient internal consistency and a negatively skewed distribution for the overall sample and monolingual and bilingual participants. Evidence for adequate convergent and discriminative validity was also established for monolingual and bilingual participants separately. Conclusion: In a diverse clinical sample with differing levels of self-reported language status, the NAB Naming Test demonstrated adequate psychometric properties. Although it represents a viable option in neuropsychological practice, continued awareness of patient-specific factors that could impact performance is recommended.

Volume 34
Pages 406 - 422
DOI 10.1080/13854046.2019.1635647
Language English
Journal The Clinical Neuropsychologist

Full Text